Regional and socioeconomic predictors of perceived ability to access coronavirus testing in the United States: results from a nationwide online COVID-19 survey.
COVID-19
Socio-economic
Testing
coronavirus
disparities
geographic
Journal
Annals of epidemiology
ISSN: 1873-2585
Titre abrégé: Ann Epidemiol
Pays: United States
ID NLM: 9100013
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
25
08
2020
revised:
10
02
2021
accepted:
01
03
2021
pubmed:
11
3
2021
medline:
4
6
2021
entrez:
10
3
2021
Statut:
ppublish
Résumé
Access to COVID-19 testing remained a salient issue during the early months of the pandemic, therefore this study aimed to identify 1) regional and 2) socioeconomic predictors of perceived ability to access Coronavirus testing. An online survey using social media-based advertising was conducted among U.S. adults in April 2020. Participants were asked whether they thought they could acquire a COVID-19 test, along with basic demographic, socioeconomic and geographic information. A total of 6,378 participants provided data on perceived access to COVID-19 testing. In adjusted analyses, we found higher income and possession of health insurance to be associated with perceived ability to access Coronavirus testing. Geographically, perceived access was highest (68%) in East South Central division and lowest (39%) in West North Central. Disparities in health insurance coverage did not directly correspond to disparities in perceived access to COVID-19 testing. Sex, geographic location, income, and insurance status were associated with perceived access to COVID-19 testing; interventions aimed at improving either access or awareness of measures taken to improve access are warranted. These findings from the pandemic's early months shed light on the importance of disaggregating perceived and true access to screening during such crises.
Identifiants
pubmed: 33691088
pii: S1047-2797(21)00038-7
doi: 10.1016/j.annepidem.2021.03.001
pmc: PMC7937327
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-14Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
J Med Internet Res. 2017 Aug 28;19(8):e290
pubmed: 28851679
Lancet. 2020 May 30;395(10238):1690-1691
pubmed: 32419711
Am J Prev Med. 2020 Sep;59(3):326-332
pubmed: 32703702
Harv Mens Health Watch. 2010 Jan;14(6):1-5
pubmed: 20464795
Am J Prev Med. 2020 Jul;59(1):137-139
pubmed: 32430225
Trans Am Clin Climatol Assoc. 2012;123:167-72; discussion 172-4
pubmed: 23303983
J Gen Intern Med. 2006 Jan;21(1):71-7
pubmed: 16423128
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Hum Vaccin Immunother. 2018 Jul 3;14(7):1665-1671
pubmed: 29333950
Am J Respir Crit Care Med. 2020 Oct 1;202(7):943-949
pubmed: 32677842
Public Health. 2015 Jun;129(6):611-20
pubmed: 26025176
Sex Reprod Health Matters. 2019 Dec;27(3):86-106
pubmed: 31880507
J Infect Public Health. 2020 May;13(5):687-691
pubmed: 32001194
Vaccine. 2017 Jan 23;35(4):508-512
pubmed: 28040206
Lancet. 2020 Mar 28;395(10229):1015-1018
pubmed: 32197103
Cureus. 2018 Jan 9;10(1):e2048
pubmed: 29541569
J Travel Med. 2020 Nov 9;27(7):
pubmed: 32412064
BMC Public Health. 2015 Feb 12;15:132
pubmed: 25881182
BMC Med Res Methodol. 2020 May 13;20(1):116
pubmed: 32404050